PL338457A1 - Sulphonylated dipeptidic compounds capable to inhibit adhesion of leucocytes through the mediation of vla-4 - Google Patents
Sulphonylated dipeptidic compounds capable to inhibit adhesion of leucocytes through the mediation of vla-4Info
- Publication number
- PL338457A1 PL338457A1 PL98338457A PL33845798A PL338457A1 PL 338457 A1 PL338457 A1 PL 338457A1 PL 98338457 A PL98338457 A PL 98338457A PL 33845798 A PL33845798 A PL 33845798A PL 338457 A1 PL338457 A1 PL 338457A1
- Authority
- PL
- Poland
- Prior art keywords
- dipeptidic
- sulphonylated
- leucocytes
- vla
- mediation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90442397A | 1997-07-31 | 1997-07-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL338457A1 true PL338457A1 (en) | 2000-11-06 |
Family
ID=25419137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL98338457A PL338457A1 (en) | 1997-07-31 | 1998-07-31 | Sulphonylated dipeptidic compounds capable to inhibit adhesion of leucocytes through the mediation of vla-4 |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0994896A1 (hu) |
JP (1) | JP2001512139A (hu) |
KR (1) | KR20010022405A (hu) |
CN (1) | CN1265672A (hu) |
AU (1) | AU8823498A (hu) |
BR (1) | BR9811594A (hu) |
CA (1) | CA2290748A1 (hu) |
HU (1) | HUP0003921A3 (hu) |
IL (1) | IL133637A0 (hu) |
NO (1) | NO20000452L (hu) |
PL (1) | PL338457A1 (hu) |
WO (1) | WO1999006437A1 (hu) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6903075B1 (en) | 1997-05-29 | 2005-06-07 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
AU7667498A (en) * | 1997-05-30 | 1998-12-30 | Celltech Therapeutics Limited | Anti-inflammatory tyrosine derivatives |
ATE249421T1 (de) | 1997-06-23 | 2003-09-15 | Tanabe Seiyaku Co | Inhibitoren der alpha4-beta1 vermittelten zelladhäsion |
AU751950B2 (en) * | 1997-11-24 | 2002-09-05 | Merck & Co., Inc. | Substituted beta-alanine derivatives as cell adhesion inhibitors |
US6645939B1 (en) | 1997-11-24 | 2003-11-11 | Merck & Co., Inc. | Substituted β-alanine derivatives as cell adhesion inhibitors |
US6197794B1 (en) * | 1998-01-08 | 2001-03-06 | Celltech Therapeutics Limited | Phenylalanine derivatives |
MY153569A (en) | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
US6329372B1 (en) | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
AU3260399A (en) | 1998-02-26 | 1999-09-15 | Celltech Therapeutics Limited | Phenylalanine derivatives as inhibitors of alpha4 integrins |
US6521626B1 (en) | 1998-03-24 | 2003-02-18 | Celltech R&D Limited | Thiocarboxamide derivatives |
GB9811159D0 (en) | 1998-05-22 | 1998-07-22 | Celltech Therapeutics Ltd | Chemical compounds |
GB9811969D0 (en) | 1998-06-03 | 1998-07-29 | Celltech Therapeutics Ltd | Chemical compounds |
US6685617B1 (en) | 1998-06-23 | 2004-02-03 | Pharmacia & Upjohn Company | Inhibitors of α4β1 mediated cell adhesion |
GB9814414D0 (en) | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
US6339101B1 (en) * | 1998-08-14 | 2002-01-15 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
US6333340B1 (en) * | 1998-08-14 | 2001-12-25 | Gpi Nil Holdings, Inc. | Small molecule sulfonamides for vision and memory disorders |
GB9821061D0 (en) | 1998-09-28 | 1998-11-18 | Celltech Therapeutics Ltd | Chemical compounds |
GB9821222D0 (en) | 1998-09-30 | 1998-11-25 | Celltech Therapeutics Ltd | Chemical compounds |
US7396526B1 (en) | 1998-11-12 | 2008-07-08 | Johnson & Johnson Consumer Companies, Inc. | Skin care composition |
GB9825652D0 (en) | 1998-11-23 | 1999-01-13 | Celltech Therapeutics Ltd | Chemical compounds |
GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
BR0008280A (pt) * | 1999-02-18 | 2001-11-06 | Hoffmann La Roche | Derivados de tioamida |
US6518283B1 (en) | 1999-05-28 | 2003-02-11 | Celltech R&D Limited | Squaric acid derivatives |
BR0013248A (pt) * | 1999-08-13 | 2002-07-23 | Biogen Inc | Inibidores da adesão celular |
US6534513B1 (en) | 1999-09-29 | 2003-03-18 | Celltech R&D Limited | Phenylalkanoic acid derivatives |
US6455539B2 (en) | 1999-12-23 | 2002-09-24 | Celltech R&D Limited | Squaric acid derivates |
NZ518886A (en) | 1999-12-28 | 2004-02-27 | Pfizer Prod Inc | Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
WO2001068586A2 (en) * | 2000-03-14 | 2001-09-20 | Novartis Ag | α4β1 AND α4β7 INTEGRIN INHIBITORS |
EP1332132B1 (en) | 2000-04-17 | 2007-10-10 | UCB Pharma, S.A. | Enamine derivatives as cell adhesion molecules |
US6545013B2 (en) | 2000-05-30 | 2003-04-08 | Celltech R&D Limited | 2,7-naphthyridine derivatives |
US6403608B1 (en) | 2000-05-30 | 2002-06-11 | Celltech R&D, Ltd. | 3-Substituted isoquinolin-1-yl derivatives |
US6740654B2 (en) | 2000-07-07 | 2004-05-25 | Celltech R & D Limited | Squaric acid derivatives |
EP1305291A1 (en) | 2000-08-02 | 2003-05-02 | Celltech R&D Limited | 3-substituted isoquinolin-1-yl derivatives |
YU12203A (sh) | 2000-08-18 | 2006-03-03 | Ajinomoto Co.Inc. | Novi derivati fenilalanina |
MY129000A (en) | 2000-08-31 | 2007-03-30 | Tanabe Seiyaku Co | INHIBITORS OF a4 MEDIATED CELL ADHESION |
US6607735B2 (en) | 2000-12-21 | 2003-08-19 | Johnson & Johnson Consumer Companies, Inc. | Method for reducing the appearance of dark circles under the eyes |
US6559174B2 (en) | 2001-03-20 | 2003-05-06 | Merck & Co., Inc. | N-arylsulfonyl aryl aza-bicyclic derivatives as potent cell adhesion inhibitors |
US6855708B2 (en) | 2001-03-20 | 2005-02-15 | Merck & Co., Inc. | N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors |
JP2004526733A (ja) * | 2001-03-20 | 2004-09-02 | メルク エンド カムパニー インコーポレーテッド | 強力な細胞接着阻害剤としての置換n−アリールスルホニル−プロリン誘導体 |
AU2003211560A1 (en) * | 2002-02-20 | 2003-09-09 | Ajinomoto Co., Inc. | Novel phenylalanine derivative |
EP1592387A4 (en) * | 2003-01-24 | 2009-05-06 | Elan Pharm Inc | COMPOSITION AND TREATMENT OF DEMYELINATING DISEASES AND PARALYSIS BY ADMINISTRATION OF REMYELINATING AGENTS |
CA2528723A1 (en) * | 2003-06-25 | 2005-01-06 | Elan Pharmaceuticals, Inc. | Methods and compositions for treating rheumatoid arthritis |
DK1683524T3 (da) * | 2003-11-14 | 2011-03-14 | Ajinomoto Kk | Dispergering på fast form eller medicinsk præparat på fast form af phenyalaninderivat |
EP1683525B1 (en) * | 2003-11-14 | 2017-05-17 | EA Pharma Co., Ltd. | Sustained-release phenylalanine derivative preparation for oral administration |
US20080317670A1 (en) * | 2005-12-14 | 2008-12-25 | Ambrx, Inc. | Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
CA2714335A1 (en) | 2007-02-20 | 2008-08-28 | Merrimack Pharmaceuticals, Inc. | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
KR20110008086A (ko) | 2008-04-11 | 2011-01-25 | 메리맥 파마슈티컬즈, 인크. | 인간 혈청 알부민 링커 및 그 콘쥬게이트 |
EP2713722B1 (en) | 2011-05-31 | 2017-03-15 | Receptos, LLC | Novel glp-1 receptor stabilizers and modulators |
CN104080767A (zh) * | 2011-12-12 | 2014-10-01 | 瑞塞普托斯公司 | 新的glp-1受体调节剂 |
AU2014278183B2 (en) * | 2013-06-11 | 2018-10-04 | Receptos Llc | Novel GLP-1 receptor modulators |
AU2015292356B2 (en) | 2014-07-25 | 2020-02-06 | Receptos Llc | Novel GLP-1 receptor modulators |
EP3230276B1 (en) | 2014-12-10 | 2020-09-02 | Celgene International II Sarl | Glp-1 receptor modulators |
US10308677B2 (en) * | 2014-12-19 | 2019-06-04 | Cem Corporation | Coupling method for peptide synthesis at elevated temperatures |
US9969769B2 (en) | 2014-12-19 | 2018-05-15 | Cem Corporation | Coupling method for peptide synthesis at elevated temperatures |
EP3873897B1 (en) | 2018-10-30 | 2024-08-14 | Gilead Sciences, Inc. | N-benzoyl-phenylalanine derivatives as alpha4beta7 integrin inhibitors for treating inflammatory diseases |
EP3873900A1 (en) | 2018-10-30 | 2021-09-08 | Gilead Sciences, Inc. | Imidazopyridine derivatives as alpha4beta7 integrin inhibitors |
US11179383B2 (en) | 2018-10-30 | 2021-11-23 | Gilead Sciences, Inc. | Compounds for inhibition of α4β7 integrin |
WO2020092375A1 (en) | 2018-10-30 | 2020-05-07 | Gilead Sciences, Inc. | Quinoline derivatives as alpha4beta7 integrin inhibitors |
CN114222730B (zh) | 2019-08-14 | 2024-09-10 | 吉利德科学公司 | 用于抑制α4β7整合素的化合物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2679903B1 (fr) * | 1991-08-02 | 1993-12-03 | Elf Sanofi | Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. |
JPH04154732A (ja) * | 1990-10-18 | 1992-05-27 | Nippon Kayaku Co Ltd | 光学分割法 |
WO1994007815A2 (en) * | 1992-09-25 | 1994-04-14 | Abbott Laboratories | Small peptide anaphylatoxin receptor ligands |
CA2150550A1 (en) * | 1992-12-01 | 1994-06-09 | Melissa S. Egbertson | Fibrinogen receptor antagonists |
AU693143B2 (en) * | 1993-12-06 | 1998-06-25 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
JPH0873422A (ja) * | 1994-09-07 | 1996-03-19 | Kdk Corp | 新規アミノ酸エステルおよび白血球、エステラーゼ又はプロテアーゼの検出方法 |
US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
-
1998
- 1998-07-31 JP JP2000505192A patent/JP2001512139A/ja not_active Withdrawn
- 1998-07-31 AU AU88234/98A patent/AU8823498A/en not_active Abandoned
- 1998-07-31 KR KR1020007000985A patent/KR20010022405A/ko not_active Application Discontinuation
- 1998-07-31 BR BR9811594-4A patent/BR9811594A/pt not_active IP Right Cessation
- 1998-07-31 HU HU0003921A patent/HUP0003921A3/hu unknown
- 1998-07-31 WO PCT/US1998/016070 patent/WO1999006437A1/en not_active Application Discontinuation
- 1998-07-31 EP EP98939871A patent/EP0994896A1/en not_active Withdrawn
- 1998-07-31 IL IL13363798A patent/IL133637A0/xx unknown
- 1998-07-31 CA CA002290748A patent/CA2290748A1/en not_active Abandoned
- 1998-07-31 CN CN98807721A patent/CN1265672A/zh active Pending
- 1998-07-31 PL PL98338457A patent/PL338457A1/xx not_active Application Discontinuation
-
2000
- 2000-01-28 NO NO20000452A patent/NO20000452L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1265672A (zh) | 2000-09-06 |
KR20010022405A (ko) | 2001-03-15 |
BR9811594A (pt) | 2000-09-05 |
HUP0003921A2 (hu) | 2001-02-28 |
WO1999006437A1 (en) | 1999-02-11 |
HUP0003921A3 (en) | 2001-03-28 |
CA2290748A1 (en) | 1999-02-11 |
NO20000452L (no) | 2000-03-27 |
EP0994896A1 (en) | 2000-04-26 |
AU8823498A (en) | 1999-02-22 |
JP2001512139A (ja) | 2001-08-21 |
NO20000452D0 (no) | 2000-01-28 |
IL133637A0 (en) | 2001-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL338457A1 (en) | Sulphonylated dipeptidic compounds capable to inhibit adhesion of leucocytes through the mediation of vla-4 | |
PL338554A1 (en) | Dipeptidic compounds inhibiting adhesion of leucocytes occurring through the mediation of vla-4 | |
PL338521A1 (en) | Carbamyloxylic compounds inhibiting adhesion of leucocytes occurring through the mediation of vla-4 | |
PL338423A1 (en) | Compounds of substituted phenylamine type capable to inhibit adhesion of leucocytes through the mediation of vla-4 | |
PL338506A1 (en) | Compounds inhibiting adhesion of leucocytes occuring through the mediation of vla-4 | |
PL338510A1 (en) | Benzyl compounds inhinbiting the adhesion of leucocytes occurring through the mediation of vla-4 | |
PL338413A1 (en) | Compound of 4-amino phenylalanine type inhibiting adhesion of leucocytes through the meditation of vla-4 | |
PL338373A1 (en) | Dipeptide and its affinite compounds inhibiting adhesion of leucocytes occurring through mediation of vla-4 | |
AU3102797A (en) | Cell adhesion inhibiting compounds | |
AU5609998A (en) | Tablet for the controlled release of active agents | |
AU5654798A (en) | Active substance carrier for releasing apomorphine into the buccal cavity | |
AU1208999A (en) | Compounds which inhibit tryptase activity | |
AU7292398A (en) | Antithrombotic compound | |
IL130957A0 (en) | Absorbent article with improved dual fastening system | |
GB9926537D0 (en) | Compounds on the basis of polyalkyl-1-oxa diazaspirodecane compounds | |
AU752953C (en) | Adding pharmaceutically active compounds to substrates | |
HUP0002719A3 (en) | Controlled release pharmaceutical preparation with ace inhibitor as active agent | |
AU1301299A (en) | Compounds which inhibit tryptase activity | |
AP9600857A0 (en) | Pharmacologically active compound | |
ZA963849B (en) | Active compound combinations | |
AU8532798A (en) | Compounds which delay the release of active substances | |
AU1786799A (en) | Composition for the controlled release of active compounds | |
AU7522898A (en) | Pseudo-peptide compounds as antagonists of neurokinines | |
AU5567798A (en) | Improvements relating to rack storage systems | |
GB9515173D0 (en) | The fighting flex |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |